Synthesis and antitumor activity of new trans-1R,2R-diaminocyclohexaneplatinum(II) complexes containing disubstituted sulfide groups

[1]  A. Khokhar,et al.  Synthesis and antitumor activity of 1,2-diaminocyclohexane platinum(IV) complexes. , 1994, Journal of inorganic biochemistry.

[2]  A. Khokhar,et al.  Synthesis, characterization, and antitumor activity of amine platinum(II) and (IV) tellurate complexes. , 1994, Journal of inorganic biochemistry.

[3]  A. Khokhar,et al.  Synthesis and antitumor activity of ammine/amine platinum(II) and (IV) complexes. , 1993, Journal of inorganic biochemistry.

[4]  N. Farrell,et al.  Sulfoxides as leaving groups. Effect of sterically hindered aliphatic sulfoxides on the antitumor activity of chloro(substituted sulfoxide)(1,1-diaminomethylcyclohexane)platinum(II) nitrate , 1992 .

[5]  L. Kèlland,et al.  Ammine/amine platinum(IV) dicarboxylates: a novel class of platinum complex exhibiting selective cytotoxicity to intrinsically cisplatin-resistant human ovarian carcinoma cell lines. , 1992, Cancer research.

[6]  R. Perez-soler,et al.  Phase I clinical and pharmacological study of liposome-entrapped cis-bis-neodecanoato-trans-R,R-1,2-diaminocyclohexane platinum(II). , 1990, Cancer research.

[7]  N. Farrell,et al.  Chemical properties and antitumor activity of complexes of platinum containing substituted sulfoxides [PtCl(R'R''SO)(diamine)]NO3. Chirality and leaving-group ability of sulfoxide affecting biological activity , 1990 .

[8]  S. Lippard,et al.  Structural aspects of platinum anticancer drug interactions with DNA , 1987 .

[9]  P. Tyle,et al.  Biochemical Mechanisms of Platinum Antitumor Drugs , 1987 .

[10]  J. Reedijk.  The mechanism of action of platinum antitumor drugs , 1987 .

[11]  D. Newell,et al.  Phase I studies with carboplatin at the Royal Marsden Hospital. , 1985, Cancer treatment reviews.

[12]  J. Macquet,et al.  Platinum-amine compounds: importance of the labile and inert ligands for their pharmacological activities toward L1210 leukemia cells. , 1983, Journal of the National Cancer Institute.

[13]  P. Pregosin.  Platinum-195 nuclear magnetic resonance , 1982 .

[14]  T. A. Connors,et al.  Structure and activity relationships of platinum complexes with anti-tumour activity. , 1975, Chemico-biological interactions.

[15]  J. Trosko,et al.  Platinum Compounds: a New Class of Potent Antitumour Agents , 1969, Nature.

[16]  J. Reedijk,et al.  Reaction products of [Pt(ethylenediamine)(dimethyl sulfoxide)Cl]Cl and [Pt(ethylenediamine)Cl2] with d(GpG) and 5'GMP. Unambiguous evidence for stable 1:1 intermediate N7 adducts with coordinated dimethyl sulfoxide , 1991 .

[17]  R. Perez-soler,et al.  Chemical and biological studies on a series of lipid-soluble (trans-(R,R)- and -(S,S)-1,2-diaminocyclohexane)platinum(II) complexes incorporated in liposomes. , 1991, Journal of medicinal chemistry.

[18]  M. Jones,et al.  Thioether suppression of cisplatin nephrotoxicity in the rat. , 1991, Anticancer research.

[19]  L S Hollis,et al.  Chemical and biological properties of a new series of cis-diammineplatinum(II) antitumor agents containing three nitrogen donors: cis-[Pt(NH3)2(N-donor)Cl]+. , 1989, Journal of medicinal chemistry.

[20]  S. Crooke,et al.  Cisplatin : current status and new developments , 1980 .

[21]  J. Hoeschele,et al.  Studies on the antitumor activity of group VIII transition metal complexes. Part I. Platinum (II) complexes , 1973 .